Page last updated: 2024-08-21

erythromycin and Obesity, Morbid

erythromycin has been researched along with Obesity, Morbid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frizzi, JD; Gustafson, RJ; Wilkinson, NW1
Miller, SD1

Trials

1 trial(s) available for erythromycin and Obesity, Morbid

ArticleYear
The effect of erythromycin on bile excretion and proximal small bowel motility following divided gastric bypass surgery: a prospective randomized placebo-controlled trial.
    Obesity surgery, 2002, Volume: 12, Issue:6

    Topics: Bile; Biliary Tract; Double-Blind Method; Duodenum; Erythromycin; Gastric Bypass; Gastrointestinal Agents; Gastrointestinal Motility; Gastrointestinal Transit; Humans; Imino Acids; Liver; Obesity, Morbid; Postoperative Period; Prospective Studies; Radionuclide Imaging

2002

Other Studies

1 other study(ies) available for erythromycin and Obesity, Morbid

ArticleYear
Madura foot: treatment of Nocardia nova infection with antibiotics alone.
    American journal of orthopedics (Belle Mead, N.J.), 2001, Volume: 30, Issue:6

    Topics: Administration, Oral; Adult; Amikacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Follow-Up Studies; Foot Bones; Foot Dermatoses; Humans; Infusions, Intravenous; Nocardia; Nocardia Infections; Obesity, Morbid; Severity of Illness Index; Treatment Outcome

2001